参考文献/References:
[1] Perry TA,Wang X,Gates L,et al.Occupation and risk of knee osteoarthritis and knee replacement: A longitudinal multiple-cohort study[J].Seminars in Arthritis and Rheumatism,2020,50(5):1006-1014.
[2] Sim HS,Ang K,How CH,et al.Management of knee osteoarthritis in primary care[J].Singapore Medical Journal,2020,61(10):512-516.
[3] Lee JY,Han K,Park YG,et al.Effects of education income and occupation on prevalence and symptoms of knee osteoarthritis[J].Scientific Reports,2021,11(1):1398-1403.
[4] Wallace IJ,Worthington S,Felson DT,et al.Knee osteoarthritis has doubled in prevalence since the mid-20th century[J].Proceedings of the National Academy of Sciences,2017,114(35):9332-9336.
[5] 王 斌,邢 丹,董圣杰,等.中国膝骨关节炎流行病学和疾病负担的系统评价[J].中国循证医学杂志,2018,18(2):134-142.
[6] Cross M,Smith E,Hoy D,et al.The global burden of hip and knee osteoarthritis: Estimates from the global burden of disease 2010 study[J].Annals of the Rheumatic Diseases,2014,73(7):1323-1330.
[7] Gilat R,Haunschild ED,Knapik DM,et al.Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis[J].International Orthopaedics,2021,45(2):345-354.
[8] Cao P,Li Y,Tang Y,et al.Pharmacotherapy for knee osteoarthritis: Current and emerging therapies[J].Expert Opinion on Pharmacotherapy,2020,21(7):797-809.
[9] Primorac D,Molnar V,Rod E,et al.Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations[J].Genes,2020,11(8):854.
[10] Bannuru RR,Osani MC,Vaysbrot EE,et al.OARSI guidelines for the non-surgical management of knee hip and polyarticular osteoarthritis[J].Osteoarthritis and Cartilage,2019,27(11):1578-1589.
[11] 时 克,王 茉,景莉君,等.基于斑马鱼毒/效同步评价的壮骨关节丸促骨骼发育作用与初步安全性研究[J].中国现代应用药学,2019,36(2):164-167.
[12] 雷文淼.壮骨关节胶囊联合玻璃酸钠对创伤性踝关节炎患者滑膜液炎性因子的影响[J].陕西中医,2017,38(1):82-83.
[13] 宋 蕾,袁晓美,毕亚男,等.壮骨关节丸对去势所致雌性小鼠骨质疏松的治疗作用[J].时珍国医国药,2020,31(2):307-310.
[14] 熊 殷,吴嘉瑞,张程亮.壮骨关节丸致肝损伤的研究进展[J].中南药学,2019,17(12): 2084-2087.
[15] 李 外.壮骨关节丸致肝损伤文献分析[J].中国中医药信息杂志,2017,24(5):122-123.
[16] Jorgensen L,Paludan AS,Laursen DR,et al.Evaluation of the cochrane tool for assessing risk of bias in randomized clinical trials:Overview of published comments and analysis of user practice in cochrane and non-cochrane reviews[J].Systematic Reviews,2016,5(1):80.
[17] 罗钧君,骆勇全,闫惠鹏.壮骨关节丸联合硫酸氨基葡萄糖胶囊治疗气滞血瘀型膝骨关节炎临床研究[J].新中医,2019,51(12):146-148.
[18] 胡 滨.壮骨关节胶囊治疗膝关节骨性关节炎60例临床研究[J].中国实用医药,2015,10(23):201-203.
[19] 王志彬,陈传杰.壮骨关节胶囊配合透明质酸钠注射液治疗老年膝骨关节炎的疗效[J].中国老年学杂志,2015,35(7):1835-1836.
[20] 张 瑞.壮骨关节胶囊配合透明质酸钠注射液治疗膝骨关节炎的疗效观察[J].临床医药文献电子杂志,2016,3(27):5483-5484.
[21] 王来福,侯芳丽.壮骨关节胶囊治疗膝关节骨性关节炎98例疗效观察[J].北方药学,2019,16(1):125-126.
[22] 张金龙,何延智.壮骨关节胶囊治疗老年性膝骨关节炎的疗效及安全性研究[J].中国老年保健医学,2019,17(4):80-82.
[23] 王志强,许 丹,冯 创.壮骨关节胶囊联合玻璃酸钠治疗膝骨关节炎的临床研究[J].现代药物与临床,2021,36(1):126-129.
[24] 许 辉,肖涟波,康冰心,等.推拿手法治疗膝骨性关节炎临床疗效及安全性Meta分析[J].陕西中医,2019,40(12):1807-1813.
[25] 武永彪,石晓兵.膝骨性关节炎中医治疗现状研究[J].陕西中医,2019,40(4):543-545.
[26] 马 锋,马敬祖,巩 凡,等.壮骨关节胶囊对SD大鼠骨性关节炎并骨质疏松症骨密度和雌激素受体表达的影响[J].中国临床研究,2017,30(3):391-394.
[27] 郭群生,韩跃波,薛宝才.壮骨关节胶囊联合玻璃酸钠治疗创伤性踝关节炎临床研究[J].实用中医药杂志,2019,35(12):1519-1520.
相似文献/References:
[1]关春辉,周占锋,李 沛.益肾荣筋汤辅助胫骨高位截骨治疗膝骨关节炎疗效 及对患者关节液内细胞因子表达水平的影响*[J].陕西中医,2019,(5):616.
GUAN Chunhui,ZHOU Zhanfeng,LI Pei..Effect of Yishen Rongjin decoction combined with high tibial osteotomy in the treatment of knee osteoarthritis and the expression level of cytokines in articular fluid〖WT4”BZ〗[J].,2019,(3):616.
[2]张 续,郑 洁,赵莉平,等.独活寄生汤对膝骨关节炎大鼠IL-17/NF-κB通路的影响[J].陕西中医,2022,(6):691.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.003]
ZHANG Xu,ZHENG Jie,ZHAO Liping,et al.Effect of Duhuo Jisheng decoction on IL-17/NF-κB signaling pathway in rats with knee osteoarthritis[J].,2022,(3):691.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.003]
[3]赵海燕,张鸿婷,李佳卓,等.温化方通过NF-κB信号通路调控大鼠膝骨关节炎实验研究[J].陕西中医,2022,(6):696.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.004]
ZHAO Haiyan,ZHANG Hongting,LI Jiazhuo,et al.Experimental study on effect of Wenhua prescription on knee osteoarthritis in rats through NF-κB signaling pathway[J].,2022,(3):696.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.004]
[4]冯文轩,肖春生.邓晋丰“通荣为要”治疗膝骨关节炎经验[J].陕西中医,2022,(6):778.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.025]
[5]张 帆,周胜利,周奕璇.膝骨关节炎中医外治研究进展[J].陕西中医,2022,(6):814.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.034]
[6]邓 昶,胡胜利,谢 维,等.中医体质与膝骨关节炎相关性研究系统评价与Meta分析[J].陕西中医,2022,(8):1135.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.035]
DENG Chang,HU Shengli,XIE Wei,et al.A systematic review and Meta-analysis of correlation between constitution of traditional Chinese medicine and knee osteoarthritis[J].,2022,(3):1135.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.035]
[7]姬 旭,武 琛,袁 芳,等.程海英教授运用贺氏三通法治疗膝骨关节炎经验[J].陕西中医,2022,(10):1452.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.032]
JI Xu,WU Chen,YUAN Fang,et al.Professor CHENG Haiying's experience in treating knee osteoarthritis with HE's three-way method[J].,2022,(3):1452.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.032]
[8]杨 娟,顾 伟,朱文俊,等.参蝎止痛胶囊治疗膝骨关节炎全膝关节置换术后疗效研究[J].陕西中医,2022,(12):1706.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.012]
YANG Juan,GU Wei,ZHU Wenjun,et al.Effect study on Shenxie Zhitong capsule of knee osteoarthritis after total knee arthroplasty[J].,2022,(3):1706.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.012]
[9]赵文勇,雷雨欣,孙智平,等.李彦民治疗膝骨关节炎经验撷萃[J].陕西中医,2022,(12):1784.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.033]
ZHAO Wenyong,LEI Yuxin,SUN Zhiping,et al.Li Yanmin's experience in treating knee osteoarthritis[J].,2022,(3):1784.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.033]
[10]刘思冶,闫 奇,汤吉祥,等.膝痹通方治疗早期膝骨关节炎肝肾亏虚证临床研究[J].陕西中医,2023,(3):307.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.008]
LIU Siye,YAN Qi,TANG Jixiang,et al.Clinical study on Xibitong prescription in treating knee osteoarthritis of early Ganshen Kuixu type[J].,2023,(3):307.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.008]